Kraig claims breakthrough in spider silk production

ANN ARBOR — Kraig Biocraft Laboratories Inc. (OTCQB: KBLB), the Ann Arbor-based developer of genetic engineering technology to create novel high-strength silk, announced what it called “a major breakthrough in the construction of DNA encoding for spider silk proteins.”

Kraig has developed techniques to splice spider genes into silkworms, leading the silkworms to produce silk that has some of the high strength properties of spiderweb material.

The new protocols were developed after Kraig Labs reached out to leading DNA synthesis facilities, which all stated that construction of the desired sequences would be practically impossible, due to the unique structure of spider silk proteins. Refusing to accept that answer, Kraig’s research team then took on the task directly.

Using a combination of distinct approaches, Kraig Labs successfully synthesized the highly complex set of spider silk protein construct designs. This new approach should accelerate the pace of its research and production rollout efforts, as well as reduce costs to develop new transgenics for new potential markets and applications.

The newly designed protein constructs are currently being prepared for incorporation into the Company’s spider silk platform technology. Due to their construction, these new designs may have the potential to produce new silk fibers with even greater strength and flexibility than the company’s current generation of recombinant “spider silk.”

“Today’s announcement is another in a long history of Kraig Labs proving the impossible, possible,” said Jon Rice, COO. “From our first transgenic silkworms, to the creation of Monster Silk and then Dragon Silk, to obtaining approvals for international expansion, the Company has proven, time and time again, that we have the tenacity to reimagine what is possible. These new constructs and the ability to rapidly adapt them could open new and wider applications in military and high performance technical textile markets. Today we celebrate yet another example of how the company is changing the rules in biotech development.”

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter or to sign up for Company alerts, visit

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.